@pastramimachine They wouldn't. I joke the one thing I learned in grad school was to not get cancelled at Harvard. In retrospect, I wish I was more vocal about humanity & rationality since most people there seem to lack both. What I would give to have been on campus and stand up for this kid...
Interesting that for tests requiring high-level use of the English language for essays (GRE Writing, AP Lang/Lit, AP WH), GPT still struggles, but for GRE Verbal (reading comp., vocab & grammar questions) it excels. I memorized essay templates for these tests and did fine...
I think these results are great for many applications, but what is missing from these models to be able to synthesize learned grammar into larger, complex bodies of work? Guess it is easier to learn how to beat the educational system than it is to be a content creator
@pranavrajpurkar I’ve noticed similar model behavior with human physiology data I’ve worked with. Could really help with keeping PHI safe, imo. A group at MIT explored a similar concept (though not on clinical data): https://t.co/yUWXENKKTz
One of my favorite points is highlighted here. Individual allegiance to a technology, that turns into group allegiance within a community of coworkers, could likely carry more weight within an organization compared to a C-suite-level decision to use/not use a new tool or product
Fascinating ideas here.
The fear large healthcare systems have towards adopting new tech causes 2 main issues (imo):
1) prevents patients from efficiently getting the best care
2) reduces the quality of life for many healthcare/science professionals
new post on @BessemerVP's Atlas 👇
introducing the new DTC: 'direct-to-clinician' go-to-markets and product-led growth in healthcare + life sciences.
from clinician influencers to #medtwitter, read why we're investing in community-centered products for next-gen professionals.
A new GTM strategy can fix this.
Considering how far behind large systems are in adopting new tech-based tools, relying directly on highly trained professionals to make their own decisions about what helps them work best makes a painful amount of sense
As always, it was fun to think of new avenues for scientific and personal growth with new friends. Was lucky enough to stumble into some fun ideas at @baxterbrewing, too!
#gradschool#innovation#academia
Had a wonderful time at the Optics and Photonics in Medicine and Biology Gordon Research Seminar & Conference last week! Thankful for all the efforts that the organizers put in to cultivate an environment where everybody felt comfortable sharing their new work & future goals.
!!!
Circulating autoantibodies neutralizing IFN-α, IFN-ω, and/or IFN-β are found in ∼20% of deceased patients across age groups [but only] in ∼1% of individuals aged <70 y and in >4% of those >70 y old in the general population.
@vandontweets Agreed with lots of the articles shared below. A book that gave me a good foundation for the space was The Entrepreneur’s Guide to a Biotech Startup by @PeterKolchinsky
@paras_biotech What is the right way to think about these plots? Mean regression due to policies & global events or a deeper lack of interest in the space? How much of the spike is due to covid-specific funding?
Proud to announce that one of our projects at Evans Lab at @MassGenBrigham has been selected by the @AWSCloud Diagnostic Development Initiative program to support our ongoing wearable device engineering & application efforts. @MassGeneralNews https://t.co/IAVOSfj6YI
I'm excited to drive this work forward! Also, I want to acknowledge that none of this would be possible without the work of other awesome people in the group. If you're interested, some of the foundational work can be found in https://t.co/4vzZB9g76U and https://t.co/7zAMdgdA48
Outside of the #PhDLife you can likely find me and my kayak somewhere in the #Boston harbor (habah?) in the summer, a ski slope in the winter, and a Boston/Cambridge brewery any time in between
The pandemic gave me lots of time to read and start thinking about who and what I want to be professionally, and I’ve recently become fascinated by the commercialization of academic innovations - a space that has been fun to explore